Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Context Therapeutics Inc.
BioNTech SE
University of Nebraska
University of Southern California
West China Hospital
Massive Bio, Inc.
University of Arizona
Jonsson Comprehensive Cancer Center
University Medical Center Groningen
Second Affiliated Hospital of Guangzhou Medical University